Ultragenyx Pharmaceutical Inc. (RARE) stock
RARENasdaqPharmaceutical PreparationsFiscal year ends December 31
$17.73+1.03 (+6.17%)
Close on Nov 18, 2026Market cap $1.75BP/E –Yield –
Ultragenyx Pharmaceutical price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Ultragenyx Pharmaceutical's price to book ratio was 232.1× on Jan 30, 2026, against 11.5× a year earlier. Over the last 5 years it ranged from 4.1× to 335.1×, with a median of 11.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jan 30, 2026 | 232.1× | +10.3 |
| 2025 | Dec 31, 2025 | 221.8× | +210.6 |
| 2024 | Dec 31, 2024 | 11.2× | −97.6 |
| 2023 | Dec 29, 2023 | 108.8× | +101.9 |
| 2022 | Dec 30, 2022 | 6.9× | +0.8 |
| 2021 | Dec 31, 2021 | 6.1× | −6.5 |
| 2020 | Dec 31, 2020 | 12.6× | +9.2 |
| 2019 | Dec 31, 2019 | 3.4× | +0.1 |
| 2018 | Dec 31, 2018 | 3.3× | −2.1 |
| 2017 | Dec 29, 2017 | 5.4× | −0.8 |
| 2016 | Dec 30, 2016 | 6.2× | −1.4 |
| 2015 | Dec 31, 2015 | 7.6× | +0.5 |
| 2014 | Dec 31, 2014 | 7.0× | – |
See a number that looks wrong?